LEVERAGING UNSTRUCTURED DATA IN ELECTRONIC HEALTH RECORDS TO DETECT ADVERSE EVENTS FROM PEDIATRIC DRUG USE - A

Su Golder1, Karen O'Connor2, Guillermo Lopez-Garcia3

  • 1Department of Health Sciences, University of York, York, United Kingdom.

Insights

Identifying adverse drug events in children using electronic health records (EHRs) is challenging. This review highlights the limited research and potential of unstructured EHR data, alongside Natural Language Processing (NLP), to improve pediatric pharmacovigilance.

Area of Science:

  • Pharmacovigilance
  • Pediatric Drug Safety
  • Health Informatics

Background:

  • Adverse drug events (ADEs) in children present significant public health concerns.
  • Research on detecting and monitoring pediatric ADEs is notably limited.
  • Electronic health records (EHRs) contain valuable unstructured data for pharmacovigilance.

Purpose of the Study:

  • To conduct a scoping review on the utilization of unstructured EHR data for identifying pediatric ADEs.
  • To assess the current state of research in this domain.
  • To identify challenges and future directions for pediatric pharmacovigilance.

Main Methods:

  • Systematic search of six major databases (MEDLINE, Embase, IEEE Xplore, etc.) in September 2024.
  • Inclusion criteria applied to identify relevant studies on pediatric ADE detection using EHRs.
  • Analysis of identified studies focusing on data sources, methodologies, and findings.

Main Results:

  • A significant research gap exists, with only nine studies meeting inclusion criteria from 984 records.
  • Unstructured EHR data shows potential for enhancing pediatric pharmacovigilance.
  • Traditional Natural Language Processing (NLP) methods have limitations in generalizability and context interpretation for ADE extraction.

Conclusions:

  • There is a critical need for more research into identifying pediatric ADEs using EHR data.
  • Advances in transformer-based models and large language models (LLMs) can overcome current NLP challenges.
  • Leveraging LLMs offers a promising avenue for large-scale utilization of EHR data in pediatric pharmacovigilance.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
755
Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
784
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
463
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
666
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.5K